Articles
Our understanding of the mechanisms of cell transformations in cancer driver genes is key to developing more effective cancer detection methods and therapeutic approaches. Test your knowledge of cancer genes and the treatments that target them. Read More ›
According to the National Cancer Institute, colorectal cancer is the fourth most frequently diagnosed cancer in the United States, with approximately 52,550 deaths from the disease occurring in 2023. As the nation spotlights colorectal cancer awareness this March, test your knowledge here! Read More ›
Immunotherapy has transformed the face of cancer care, and according to the AACR, it’s one of the 5 pillars of cancer treatment. How much do you know about immunotherapy? Test your knowledge here! Read More ›
Navigating today’s healthcare system can be challenging for anyone, but for older adults, it can be especially difficult. From scheduling appointments to engaging with clinicians to interpreting health insurance coverage, trying to secure the best medical care can be overwhelming, resulting in poor clinical outcomes, emotional distress, and reduced quality of life. Read More ›
Drinking alcohol increases the risk of at least 7 types of cancers. Read More ›
By Angela Long
Artificial intelligence (AI) chatbots showed mixed results when it came to providing treatment strategies and direct-to-patient cancer advice for a variety of malignancies, according to 2 studies recently published in JAMA Oncology. Read More ›
By William King
Madrid, Spain—A perioperative regimen of neoadjuvant nivolumab (Opdivo) plus chemotherapy followed by surgery and adjuvant nivolumab demonstrated a statistically significant and clinically meaningful improvement in event-free survival (EFS) versus neoadjuvant chemotherapy plus placebo followed by surgery and adjuvant placebo in patients with resectable non–small cell lung cancer. Read More ›
This section provides a brief overview of new cancer drugs and new indications approved by the FDA between September 11, 2023, and October 16, 2023. Read More ›
Improving clinical outcomes in the second line of treatment in patients with advanced biliary tract cancer remains an important goal, and researchers have been exploring various therapeutic targets, including HER2, an oncogene that creates a protein that encourages cell growth and accelerates the spread of cancers. Read More ›